Abstract
BACKGROUND AND PURPOSE •There is no consensus for the treatment of recurrent rectal cancer. • As FOLFOX has been the standard adjuvant chemotherapy, most recurrent patients have received oxaliplatin previously. •This study is to investigate the local effect and toxicity of irinotecan and capacitabine concurrent with intensity-modulated radiation therapy in the treatment of recurrent rectal cancer.
Full Text
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call